BLCO (Medical supplies) Stock Valuation & Fair Value Mixed on our tests
BLCO (Medical supplies) trades at a current P/E of 23.4, about 6% below its historical normal valuation, with a forward growth estimate of 36.3% and a PEG of 0.65. Analysts' one-year estimates have been hit 33% of the time. Priced at its historical normal P/E of 25.0 on the same blended earnings, the 2026-10-23 close of $17.47 corresponds to about $18.70 a share. This is a valuation reference, not a price target.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
Valuation flags
- Misses analyst estimates often (100%)
Frequently asked questions
Is BLCO overvalued?
At a current P/E of 23.4 versus its historical normal P/E of 25.0, BLCO trades about 6% below its typical valuation, with a PEG of 0.65 on 36.3% forward growth. tickerseer currently rates it mixed on our tests.
What is BLCO's fair value and PEG?
BLCO trades at a current P/E of 23.4 against a historical normal P/E of 25.0, a PEG of 0.65, and a forward growth estimate of 36.3%. Priced at its historical normal P/E of 25.0 on the same blended earnings, the 2026-10-23 close of $17.47 corresponds to about $18.70 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of BLCO changed?
tickerseer's rating has been mixed on our tests since 2026-10-24.
Industry: Medical supplies. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.